Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px

Persons > Région Lémanique

Find below persons from the Région Lémanique in Switzerland. Listed are persons from this region as well as persons belonging to organisations located there.

Total search results: 176 | Ordered by Person (ascending)
1 2  next pagenext page

order ascendingorder descendingPerson order ascendingorder descendingPosition order ascendingorder descendingOrganisation (Group) order ascendingorder descendingRegion
Adams, Timothy M. (Tim) (ObsEva 201701– CFO located in US before Demandware + athenahealth + Cytyc) Chief Financial Officer (CFO) ObsEva (Group) Plan-les-Ouates GE
Aebischer, Patrick (Ecole Polytechnique Fédérale 200808) n. a. EPFL (Ecole Polytechnique Fédérale de Lausanne) Lausanne VD
Affentranger, Anton (Affentranger Associates 200803 CEO + Senior Partner + founder before Roche CFO) Chief Executive Officer (CEO) Affentranger Associates S.A. Genève (Geneva) GE
Allemond, Pierre (Protein Metrics 201510– VP European Sales before Biovia/Dassault Systèmes + Accelrys + Chemspeed) Sales Manager / Marketing Manager Protein Metrics Inc. Genève (Geneva) GE
Augsburger, Marc (CURML-UTCF 201005 Operational Manager) n. a. University of Lausanne (UNIL) Lausanne VD
Bairoch, Amos (Swiss Institute of Bioinformatics 2009 Professor) Professor Swiss Institute of Bioinformatics (SIB) Lausanne VD
Ballmer, Allison (Biocartis 201212 Global Marketing Manager DMAT) Sales Manager / Marketing Manager Biocartis (Group) Lausanne VD
Barbut, Jack (Novimmune 201012–201512 CEO until 12/15) Chief Executive Officer (CEO) Novimmune S.A. Plan-les-Ouates GE
Behar, Greg (Nestlé 201509 CEO of Nestlé Health Science) Chief Executive Officer (CEO) Nestlé (Group) Lutry VD
Beher, Dirk (Asceneuron 201509 CEO) Chief Executive Officer (CEO) Asceneuron S.A. Lausanne VD
Ben-Zeev, Iris (Kenes 201308 Event Manager) Event Manager / Conference Manager Kenes (Group) Genève (Geneva) GE
Bertarelli, Ernesto (Serono 200412 CEO + major owner) Chief Executive Officer (CEO) Merck (DE) (Group) Genève (Geneva) GE
Bocci, Marco (Selexis 201311– Director European Sales + Business Development before Quintiles) Sales Manager / Marketing Manager Selexis (Group) Plan-les-Ouates GE
Bolliger, Luca (Novimmune 201012 Director Business Development + Communication) Business Development Manager / Strategy Manager Novimmune S.A. Plan-les-Ouates GE
Botti, Paolo (Arisgen 2007) n. a. ArisGen S.A. Plan-les-Ouates GE
Bozotti, Carlo (STMicroelectronics 200702 Pres + CEO) Chief Executive Officer (CEO) STMicroelectronics (Group) Plan-les-Ouates GE
Brabeck-Letmathe, Peter (Nestlé –200711– Chairman + CEO) Chief Executive Officer (CEO) Nestlé (Group) Vevey VD
Bulcke, Paul (Nestlé 201402 CEO) Chief Executive Officer (CEO) Nestlé (Group) Vevey VD
Camblong, Jurgi (Sophion Genetics 201407 CEO + Co-Founder) Chief Executive Officer (CEO) Sophia Genetics (Group) Lausanne VD
Cantarell, Luis (Nestlé 201105 CEO of Nestlé Health Science SA) Chief Executive Officer (CEO) Nestlé (Group) Lutry VD
Charlon, Vincent (Anergis 201103 CEO) Chief Executive Officer (CEO) Anergis S.A. Epalinges VD
Ciftlik, Ata Tuna (Lunaphore Technologies 201404– CEO + Co-Founder) Chief Executive Officer (CEO) Lunaphore Technologies S.A. Lausanne VD
Conquet, Francois (Prexton Therapeutics 201207– CEO + founder) Chief Executive Officer (CEO) Prexton Therapeutics S.A. Plan-les-Ouates GE
Constant, Samuel (Epithelix 201207 COO + Co-founder) Chief Operating Officer (COO) Epithelix Sàrl Plan-les-Ouates GE
Cordes, Ulrik (Biocartis 201309– CCO before Thermo Fisher + Dako A/S + Pharmacia Biotech A/S) Chief Commercial Officer (CCO) Biocartis (Group) Lausanne VD
Cotte, Yann (Nanolive 201602 Managing Director) Managing Director Nanolive S.A. Ecublens VD
Coukos, George (Univ Lausanne 201601 Prof + Director of Ludwig Institute for Cancer Research) Professor University of Lausanne (UNIL) Lausanne VD
Courtine, Grégoire (EPFL + CHUV 201604 + G-Therapeutics 201604 CSO + Co-Founder) Professor EPFL (Ecole Polytechnique Fédérale de Lausanne) Lausanne VD
Cunha, Fernando (AB2 Bio 201602 CFO) Chief Financial Officer (CFO) AB2 Bio Ltd. (CH) Lausanne VD
Curtin, Francois (Geneuro 201207 CEO) Chief Executive Officer (CEO) GeNeuro S.A. (Euronext Paris: GNRO) Plan-les-Ouates GE
Dabu, Ferdinand (SGS 201011 Global Marketing Director Life Sciences Services R&D/QC) Sales Manager / Marketing Manager SGS (Group) Genève (Geneva) GE
Damour, Bertrand (OncoEthix 201101– CEO before Egalet CFO + GeneProt CEO + CFO + JP Morgan London) Chief Executive Officer (CEO) Merck (US) (Group) Lausanne VD
de Boer, Mark (Index Ventures 200708 General Partner) Venture Partner Index Ventures Genève (Geneva) GE
de Buman, Jean-Luc (SGS 201505 Corp Development, Communications + PR) Public Relations Manager / Investor Relations Manager SGS (Group) Genève (Geneva) GE
de Rubertis, Francesco (Medecxi Ventures 201602 General Partner before Index Ventures 200708 General Partner) General Partner (venture partner) Medicxi Ventures (formerly Index Ventures Life Sciences) London, Greater London
Decouttere, Frederik (Genohm 2010– CEO before CTO since 2002) Chief Executive Officer (CEO) Genohm (Group) Lausanne VD
Deperthes, David (Debiopharm 201306 VP Business Development) Business Development Manager / Strategy Manager Debiopharm (Group) Lausanne VD
Derouazi, Madiha (Amal Therapeutics 201209– CEO + Founder) Chief Executive Officer (CEO) Amal Therapeutics S.A. Genève (Geneva) GE
Donoghue, John P. (Brown University 201408 Professor + Wyss Center at Campus Biotech Geneva) Professor Brown University Providence, RI
du Buman, Jean-Luc (SGS 201609 Corp Developm + Communications + PR) Public Relations Manager / Investor Relations Manager SGS (Group) Genève (Geneva) GE
Dubuis, Benoît (Campus Biotech Geneva 201601 Site Director) President/Director/Head Business Group/Unit/Division Campus Biotech (Geneva, former Merck Serono site) Genève (Geneva) GE
Ducrey, Bertrand (Debiopharm 201610 CEO of Debiopharm International) Chief Executive Officer (CEO) Debiopharm (Group) Lausanne VD
Dumont, Jean-Maurice (Debiopharm 201504 VP Medical Affairs) Chief Medical Officer (CMO) Debiopharm (Group) Lausanne VD
Durand, Nicolas (Abionic 201604 CEO + Co-Founder) Chief Executive Officer (CEO) Abionic S.A. Lausanne VD
Dyer, Tim (Addex CFO + Co-Founder LEFT 5/13) Chief Financial Officer (CFO) Addex (Group) Plan-les-Ouates GE
Elger, Daniel (Genkyotec 201406– CFO + Chief Development Officer before e-Therapeutics plc + Antisoma) Chief Financial Officer (CFO) Genkyotex (Group) Plan-les-Ouates GE
Epping-Jordan, Mark (Addex Pharma –200806 CSO) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Addex (Group) Plan-les-Ouates GE
Essinger, Jacques R. (Symetis 201703 CEO) Chief Executive Officer (CEO) Boston Scientific (Group) Ecublens VD
Farinelli, Laurent (Fasteris 200901 CEO + co-founder Chief Executive Officer (CEO) Fasteris S.A. Plan-les-Ouates GE
Fathi, Marc (University Geneva 201008 HUG Toxicology Lab) Researcher (university / research institute) University of Geneva (Université de Genève, UNIGE) Genève (Geneva) GE
Fisch, Igor (Selexis 201008 CEO + co-founder) Chief Executive Officer (CEO) Selexis (Group) Plan-les-Ouates GE
Fleck, Roman (Index Ventures 2006– Principal at Geneva office before Boehringer Ingelheim) Principal (venture capital) Index Ventures Genève (Geneva) GE
Fleurant, Mylène (Novimmune 201609– Global Head of Quality before Alvotech + Novartis Pharma + Merck Serono) Chief Financial Officer (CFO) Novimmune S.A. Plan-les-Ouates GE
Forer, Michael (Celtic Therapeutics 201207 CEO of ADC Therapeutics until 6/15 + Partner in Celtic Therapeutics) Chief Executive Officer (CEO) Auven Therapeutics (Group) Lausanne VD
Freitag, Chris (Debiopharm International 201610 VP Clinical RnD) Chief Medical Officer (CMO) Debiopharm (Group) Lausanne VD
Fulpius, Nicolas (Affentranger Associates 200803 Partner before Ultreia Capital Investment Director) Partner (venture partner) Affentranger Associates S.A. Genève (Geneva) GE
Girod, Pierre-Alain (Selexis 201610 CSO) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Selexis (Group) Plan-les-Ouates GE
Gonçalves, Dulce (Auven Therapeutics 201409– Corporate Counsel at ADC Therapeutics before Novartis) General Counsel Auven Therapeutics (Group) Lausanne VD
Gotteland, Jean-Pierre (ObsEva 201701 CSO) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) ObsEva (Group) Plan-les-Ouates GE
Goundis, Dimitri (MaxiVax 201602– CEO before Acrongenomics + Speedel + Medicines Co Inc + Roche) Chief Executive Officer (CEO) MaxiVax S.A. Genève (Geneva) GE
Guillarme, Davy (Univ Geneva 201704) Researcher (university / research institute) University of Geneva (Université de Genève, UNIGE) Genève (Geneva) GE
Hall, Matthew (SimplicityBio SA 201610 CSO + Co-Founder) n. a. SimplicityBio S.A. Monthey VS
Harrison, Clark (Biocartis 201201– COO before Leica Biosystems VP Global Operations) Chief Operating Officer (COO) Biocartis (Group) Lausanne VD
Hediard, Florent (SGS 201610 Life Sciences Marketing Director Agriculture + Food + Life) Sales Manager / Marketing Manager SGS (Group) Genève (Geneva) GE
Heintze, Déborah (Lunaphore Technologies 201404– COO + Co-Founder) Chief Operating Officer (COO) Lunaphore Technologies S.A. Lausanne VD
Henchoz, Stéphane (Auven Therapeutics 201409– Director of Finance at ADC Therapeutics before Merck Serono) Chief Financial Officer (CFO) Auven Therapeutics (Group) Lausanne VD
Herklots, Hans (Carpicorn One 200704– Manaing Director + TiGenix 201204 Director Investor + Media Relations) Public Relations Manager / Investor Relations Manager Capricorn One – Hans Herklots Genève (Geneva) GE
Hildinger, Markus (ExcellGene 200905 CBO) Chief Business Officer (CBO) ExcellGene S.A. Monthey VS
Hochstrasser, Denis (University Geneva 201005 Professor HUG Head Dept Genetic and Laboratory Medicine) Professor University of Geneva (Université de Genève, UNIGE) Genève (Geneva) GE
Hoenlinger, Sheida (SGS 201610 Director Life Sciences Germany) President/Director/Head Business Group/Unit/Division SGS (Group) Genève (Geneva) GE
Hofmeister, Anton (STMicroelectronics 200509) n. a. STMicroelectronics (Group) Plan-les-Ouates GE
Holdener, Eduard (Ed) (Novimmune 201512– CEO before Roche CMO) Chief Executive Officer (CEO) Novimmune S.A. Plan-les-Ouates GE
Hopfgartner, Gérard (Univ Geneva 201003 Professor) Professor University of Geneva (Université de Genève, UNIGE) Genève (Geneva) GE
Hornstein, Jörg (AC Immune 201701– CFO before Theo Müller Group + Merck KGaA) Chief Financial Officer (CFO) AC Immune S.A. (Nasdaq: ACIU) Lausanne VD
Huang, Song (Epithelix 201207 CSO + Co-founder) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Epithelix Sàrl Plan-les-Ouates GE
Hubbell, Jeffrey A. (Anokion 201701 Chairman + CSO + Academic Founder + Prof at Univ Chicago + before at EPFL) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Anokion (Group) Ecublens VD
Kempers, Ronald (Mymetics 201008 CFO before COO since July 2009) Chief Financial Officer (CFO) Mymetics Corporation Epalinges VD
Keywood, Charlotte (Zambon 201603 Head RnD before Addex Pharma CMO) Research & Development Manager Zambon (Group) Bresso (MI)
Kholmyansky, Ira (Kenes 201601 Industry Business Intelligence) n. a. Kenes (Group) Genève (Geneva) GE
Kirk, Chris (SGS 201011 CEO) Chief Executive Officer (CEO) SGS (Group) Genève (Geneva) GE
Klinger, Olaf (Merck Serono S.A. 200701 CFO) Chief Financial Officer (CFO) Merck (DE) (Group) Genève (Geneva) GE
Ladestein, Paul (MyCartis 201409– CEO before Biocartis 201404 Managing Director of business unit Evalution + Luminex) Chief Executive Officer (CEO) MyCartis Lausanne VD
Latrille, Frank (Merck Serono 200701 Head of Product Development) n. a. Merck (DE) (Group) Genève (Geneva) GE
Laue, Carsten (Medipol 201108 Managing Director) Managing Director Medipol S.A. Lausanne VD
Loiret-Bernal, Cédric (GeneProt 200009 CEO) Chief Executive Officer (CEO) GeneProt Inc. Satigny GE
Lopriore, Stefano (STMicroelectronics 200506) n. a. STMicroelectronics (Group) Plan-les-Ouates GE
Loumaye, Ernest (ObsEva 201211– CEO + Co-founder before PregLem SA CEO + founder + Ipsen + Serono) Chief Executive Officer (CEO) ObsEva (Group) Plan-les-Ouates GE
Lynch, Mike (Invoke Capital Founder) Chief Executive Officer (CEO) Invoke Capital (Myke Lynch) Cambridge, Cambridgeshire
Maggos, Chris (LifeSci Advisors 201511 Managing Director Europe before Addex 201106–201302 BusDev + Communication) Public Relations Manager / Investor Relations Manager LifeSci Advisors LLC New York, NY
Manore, Hadar (Paragon Conventions 201304 Project Manager – Industry Liaison) Event Manager / Conference Manager Paragon (IL) (Group) Genève (Geneva) GE
Marriott, Peter (SGS 201012 Global Technical & Accreditation Manager) Technical Manager SGS (Group) Genève (Geneva) GE
Martello, Wan Ling (Nestlé 201402 CFO) Chief Financial Officer (CFO) Nestlé (Group) Vevey VD
Martin, Chris (Auven Therapeutics 201506 CEO of ADC Therapeutics before CEO of Spirogen Ltd) Managing Director Auven Therapeutics (Group) Lausanne VD
Martin, Jacques-François (Parteurop Pharma 201602 President + Founder before Mymetics + Chiron Vaccines) Chief Executive Officer (CEO) Parteurop Pharma (FR) Lyon
Martin-Garcia, Jesús (Eclosion 201207 General Partner + Founder + GeNeuro 201512 CEO) General Partner (venture partner) Eclosion S.A. Plan-les-Ouates GE
Massouras, Andreas (Saphetor SA 201604 CEO + Founder before Citigroup + Credit Suisse + Salomon Brothers) Chief Executive Officer (CEO) Saphetor S.A. Lausanne VD
Massuyeau, Laurent (Addex 200804–200909 Head Business Developm before Idenix RESIGNED 9/09 at Addex) Business Development Manager / Strategy Manager Addex (Group) Plan-les-Ouates GE
Mauvernay, Rolland-Yves (Debiopharm 201301 President + Founder) President/Director/Head Business Group/Unit/Division Debiopharm (Group) Lausanne VD
Mauvernay, Thierry (Debiopharm 201306 Board Member) Board member Debiopharm (Group) Lausanne VD
McAllister, Andres (Debiopharm 201306 CSO Resesearch + Evaluation) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Debiopharm (Group) Lausanne VD
1 2  next pagenext page



Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BCNP Consultants European Chemistry Partnering 2018 Ffm 120x180px Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 120x180px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture BCNP Consultants European Chemistry Partnering 2018 Ffm 120x180px